Renal involvement in preeclampsia: similarities to VEGF ablation therapy
- PMID: 21494322
- PMCID: PMC3066648
- DOI: 10.1155/2011/176973
Renal involvement in preeclampsia: similarities to VEGF ablation therapy
Abstract
Glomerular VEGF expression is critical for the maintenance and function of an intact filtration barrier. Alterations in glomerular VEGF bioavailability result in endothelial as well as in podocyte damage. Renal involvement in preeclampsia includes proteinuria, podocyturia, elevated blood pressure, edema, glomerular capillary endotheliosis, and thrombotic microangiopathy. At least the renal signs, symptoms, and other evidence can sufficiently be explained by reduced VEGF levels. The aim of this paper was to summarize our pathophysiological understanding of the renal involvement of preeclampsia and point out similarities to the renal side effects of VEGF-ablation therapy.
Figures
References
-
- Walker JJ. Pre-eclampsia. Lancet. 2000;356(9237):1260–1265. - PubMed
-
- He H, Venema VJ, Gu X, Venema RC, Marrero MB, Caldwell RB. Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through Flk-1/KDR activation of c-Src. Journal of Biological Chemistry. 1999;274(35):25130–25135. - PubMed
-
- Simon M, Grone HJ, Johren O, et al. Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney. American Journal of Physiology—Renal Fluid and Electrolyte Physiology. 1995;268(2):F240–F250. - PubMed
-
- de Vivo A, Baviera G, Giordano D, Todarello G, Corrado F, D’Anna R. Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia. Acta Obstetricia et Gynecologica Scandinavica. 2008;87(8):837–842. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
